Cover Image
Market Research Report
Product code 
1042719

Oncology Market in India 2021-2025

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Oncology Market in India 2021-2025
Published: December 12, 2021
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

Technavio has been monitoring the oncology market in India and it is poised to grow by $ 734.18 million during 2021-2025, progressing at a CAGR of 13.02% during the forecast period. Our report on the oncology market in India provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increased prevalence of cancer and unhealthy lifestyle. In addition, increased prevalence of cancer is anticipated to boost the growth of the market as well.

The oncology market in India analysis includes the end-user and type segments.

Technavio's oncology market in India is segmented as below:

By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Diagnostic Imaging Centers
  • Others

By Type

  • Cancer Treatment
  • Cancer Diagnostics

This study identifies the increasing geriatric populationas one of the prime reasons driving the oncology market growth in India during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on oncology market in India covers the following areas:

  • Oncology market sizing
  • Oncology market forecast
  • Oncology market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oncology market vendors in India that include AstraZeneca Plc, Bristol-Myers Squibb Co., Cadila Healthcare Ltd., Cipla Inc., F. Hoffmann-La Roche Ltd., Merck and Co. Inc., NATCO Pharma Ltd., Poly Medicure Ltd., Siemens Healthineers AG, and Sun Pharmaceutical Industries Ltd. Also, the oncology market in India analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR71137

Table of Contents

  • Executive Summary
    • Market Overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by End-user
    • Market segments
    • Comparison by End-user
    • Hospitals - Market size and forecast 2020-2025
    • Diagnostic Laboratories - Market size and forecast 2020-2025
    • Diagnostic Imaging Centers - Market size and forecast 2020-2025
    • Others - Market size and forecast 2020-2025
    • Market opportunity by End-user
  • Market Segmentation by Type
    • Market segments
    • Comparison by Type
    • Cancer Treatment - Market size and forecast 2020-2025
    • Cancer Diagnostics - Market size and forecast 2020-2025
    • Market opportunity by Type
  • Customer landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Vendor landscape
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • AstraZeneca Plc
    • Bristol-Myers Squibb Co.
    • Cadila Healthcare Ltd.
    • Cipla Inc.
    • F. Hoffmann-La Roche Ltd.
    • Merck and Co. Inc.
    • NATCO Pharma Ltd.
    • Poly Medicure Ltd.
    • Siemens Healthineers AG
    • Sun Pharmaceutical Industries Ltd.
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 5
  • 4: Key Finding 6
  • 5: Key Finding 7
  • 6: Parent market
  • 7: Market characteristics
  • 8: Offerings of vendors included in the market definition
  • 9: Market segments
  • 10: Global - Market size and forecast 2020 - 2025 ($ million)
  • 11: Global market: Year-over-year growth 2020 - 2025 (%)
  • 12: Five forces analysis 2020 & 2025
  • 13: Bargaining power of buyers
  • 14: Bargaining power of suppliers
  • 15: Threat of new entrants
  • 16: Threat of substitutes
  • 17: Threat of rivalry
  • 18: Market condition - Five forces 2020
  • 19: End-user - Market share 2020-2025 (%)
  • 20: Comparison by End-user
  • 21: Hospitals - Market size and forecast 2020-2025 ($ million)
  • 22: Hospitals - Year-over-year growth 2020-2025 (%)
  • 23: Diagnostic Laboratories - Market size and forecast 2020-2025 ($ million)
  • 24: Diagnostic Laboratories - Year-over-year growth 2020-2025 (%)
  • 25: Diagnostic Imaging Centers - Market size and forecast 2020-2025 ($ million)
  • 26: Diagnostic Imaging Centers - Year-over-year growth 2020-2025 (%)
  • 27: Others - Market size and forecast 2020-2025 ($ million)
  • 28: Others - Year-over-year growth 2020-2025 (%)
  • 29: Market opportunity by End-user
  • 30: Type - Market share 2020-2025 (%)
  • 31: Comparison by Type
  • 32: Cancer Treatment - Market size and forecast 2020-2025 ($ million)
  • 33: Cancer Treatment - Year-over-year growth 2020-2025 (%)
  • 34: Cancer Diagnostics - Market size and forecast 2020-2025 ($ million)
  • 35: Cancer Diagnostics - Year-over-year growth 2020-2025 (%)
  • 36: Market opportunity by Type
  • 37: Customer landscape
  • 38: Impact of drivers and challenges
  • 39: Vendor landscape
  • 40: Landscape disruption
  • 41: Industry risks
  • 42: Vendors covered
  • 43: Market positioning of vendors
  • 44: AstraZeneca Plc - Overview
  • 45: AstraZeneca Plc - Product and service
  • 46: AstraZeneca Plc - Key offerings
  • 47: AstraZeneca Plc - Key customers
  • 48: AstraZeneca Plc - Segment focus
  • 49: Bristol-Myers Squibb Co. - Overview
  • 50: Bristol-Myers Squibb Co. - Product and service
  • 51: Bristol-Myers Squibb Co. - Key offerings
  • 52: Bristol-Myers Squibb Co. - Key customers
  • 53: Bristol-Myers Squibb Co. - Segment focus
  • 54: Cadila Healthcare Ltd. - Overview
  • 55: Cadila Healthcare Ltd. - Business segments
  • 56: Cadila Healthcare Ltd. - Key offerings
  • 57: Cadila Healthcare Ltd. - Key customers
  • 58: Cadila Healthcare Ltd. - Segment focus
  • 59: Cipla Inc. - Overview
  • 60: Cipla Inc. - Business segments
  • 61: Cipla Inc. - Key offerings
  • 62: Cipla Inc. - Key customers
  • 63: Cipla Inc. - Segment focus
  • 64: F. Hoffmann-La Roche Ltd. - Overview
  • 65: F. Hoffmann-La Roche Ltd. - Business segments
  • 66: F. Hoffmann-La Roche Ltd. - Key offerings
  • 67: F. Hoffmann-La Roche Ltd. - Key customers
  • 68: F. Hoffmann-La Roche Ltd. - Segment focus
  • 69: Merck and Co. Inc. - Overview
  • 70: Merck and Co. Inc. - Business segments
  • 71: Merck and Co. Inc. - Key offerings
  • 72: Merck and Co. Inc. - Key customers
  • 73: Merck and Co. Inc. - Segment focus
  • 74: NATCO Pharma Ltd. - Overview
  • 75: NATCO Pharma Ltd. - Business segments
  • 76: NATCO Pharma Ltd. - Key offerings
  • 77: NATCO Pharma Ltd. - Key customers
  • 78: NATCO Pharma Ltd. - Segment focus
  • 79: Poly Medicure Ltd. - Overview
  • 80: Poly Medicure Ltd. - Business segments
  • 81: Poly Medicure Ltd. - Key offerings
  • 82: Poly Medicure Ltd. - Key customers
  • 83: Poly Medicure Ltd. - Segment focus
  • 84: Siemens Healthineers AG - Overview
  • 85: Siemens Healthineers AG - Business segments
  • 86: Siemens Healthineers AG - Key offerings
  • 87: Siemens Healthineers AG - Key customers
  • 88: Siemens Healthineers AG - Segment focus
  • 89: Sun Pharmaceutical Industries Ltd. - Overview
  • 90: Sun Pharmaceutical Industries Ltd. - Product and service
  • 91: Sun Pharmaceutical Industries Ltd. - Key offerings
  • 92: Sun Pharmaceutical Industries Ltd. - Key customers
  • 93: Sun Pharmaceutical Industries Ltd. - Segment focus
  • 94: Currency conversion rates for US$
  • 95: Research Methodology
  • 96: Validation techniques employed for market sizing
  • 97: Information sources
  • 98: List of abbreviations